An observational study in Spinal Stenosis Lumbar and Neuropathic Pain, sponsored by Marmara University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-07.
Sponsored by Marmara University · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 79 studies in Neuralgia with a site in Turkey — 29 open to participants now, 30 under way, none of them phase 3. Neuralgia · Turkey.
Among the 79 studies in Neuralgia with a site in Turkey, this one is the 18th largest by planned enrollment of the 43 observational ones that give a count, is one of 19 that started in 2026, is one of 43 observational ones, reaches primary completion later than 20 of the 29 other live ones, and was the 79th registered.
1,103 studies on the registry are indexed under Neuralgia; 243 are open to participants now.
Browse Neuralgia studies →29 of the 79 studies in Neuralgia with a site in Turkey are open now. Recruiting first, the newest first:
Istanbul Physical Medicine Rehabilitation Training and Research Hospital · Sites in Turkey
Ages 18–65
Kutahya Health Sciences University · Sites in Turkey
Ages 18+
Gaziler Physical Medicine and Rehabilitation Education and Research Hospital · Sites in Turkey
Ages 18–65
Marmara University · Sites in Turkey
Ages 18–65
Istanbul Training and Research Hospital · Sites in Turkey
Ages 18+
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 155 Neuralgia studies recruiting now, 79 (51%) set no upper age limit and 44 (28%) stop at 75 or younger; 8 take children under 18; 12 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
79 studies; the count open now beside each. This study's row is marked.
First in 2010; this study’s year is marked. 19 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 100 is close to the median of 102 across 232 observational studies indexed under Neuralgia.
Median enrollment 60 across the 36 interventional studies, 96 across the 43 observational. Of the 42 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 79 has an industry lead sponsor. The 10 most frequent:
Marmara University is the lead sponsor of 601 studies on the registry; 137 are open to participants now.
Marmara University has 7 studies filed under Neuralgia — fewer than ten, so there is no comparison to draw.
14 of the studies in Neuralgia with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07846410Istanbul Physical Medicine Rehabilitation Training and Research HospitalVirtual Reality-Based Hypnotherapy for Pain, Sleep, and Mood in Spinal Cord Injury | 2026-11 |
| NCT07844772Istanbul Training and Research HospitalSerum Substance P, Neuropathic Pain, and Central Sensitization Across Treatment Groups in Chronic Plaque Psoriasis | 2026-12 |
| NCT06430918Bozyaka Training and Research HospitalNeuropathic Pain and it's Relation to Sleep Quality in Knee Osteoarthritis | 2026-12-01 |
| NCT07550348Ataturk UniversityBupivacaine-Lidocaine vs Bupivacaine for Ultrasound-Guided Popliteal Sciatic Nerve Block | 2026-12-01 |
| NCT07596823Ankara City Hospital BilkentHematological Indices and Sympathetic Block Response in Neuropathic Pain | 2026-12-31 |
Add all 14 to your calendar (.ics) → With an account.
Among the 79 studies in Neuralgia with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This cross-sectional observational study aims to evaluate neuropathic pain severity in patients with lumbar spinal stenosis (LSS) and to investigate its association with radiological findings. Neuropathic pain will be evaluated using the Neuropathic Pain Symptom Inventory (NPSI). Pain intensity, neuropathic pain characteristics, functional status, walking capacity, and psychological symptoms will also be assessed. The relationships between NPSI scores and clinical, functional, psychological, and radiological parameters will be investigated.
Adult patients with clinically and radiologically confirmed lumbar spinal stenosis who present with low back and/or leg pain or symptoms of neurogenic claudication.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Cancer that has spread from where it began to other parts of the body. “Metastatic” cancer is cancer that has spread this way.
Cancer (malignancy)
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Metastases
Cancer that has spread from where it began to other parts of the body. “Metastatic” cancer is cancer that has spread this way.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients diagnosed with lumbar spinal stenosis based on clinical and magnetic resonance imaging (MRI) findings. Participants will undergo a single cross-sectional assessment including neuropathic pain symptoms, pain intensity, functional status, walking capacity, psychological symptoms, and radiological severity.
Neuropathic Pain Symptom Inventory Total Intensity Score
Neuropathic pain symptom intensity will be assessed using the Neuropathic Pain Symptom Inventory (NPSI). The total intensity score is calculated as the sum of 10 symptom descriptor scores and ranges from 0 to 100, with higher scores indicating greater neuropathic pain symptom intensity.
Time frame: Single assessment at baseline
Correlation Between Neuropathic Pain Symptom Inventory Total Intensity Score and Radiological Severity of Lumbar Spinal Stenosis
The correlation between the Neuropathic Pain Symptom Inventory (NPSI) total intensity score (range, 0-100; higher scores indicate greater neuropathic pain symptom intensity) and radiological severity of lumbar spinal stenosis assessed on lumbar magnetic resonance imaging using the Schizas grading system will be evaluated.
Time frame: Single assessment at baseline
Correlation Between Neuropathic Pain Symptom Inventory Total Intensity Score and Leg Pain Intensity
The correlation between the NPSI total intensity score (range, 0-100; higher scores indicate greater neuropathic pain symptom intensity) and leg pain intensity assessed using the 11-point Numeric Rating Scale (NRS; 0 = no pain and 10 = worst imaginable pain) will be evaluated.
Time frame: Single assessment at baseline
Correlation Between Neuropathic Pain Symptom Inventory Total Intensity Score and Functional Disability
The correlation between the NPSI total intensity score (range, 0-100; higher scores indicate greater neuropathic pain symptom intensity) and functional disability assessed using the Oswestry Disability Index (ODI) will be evaluated. Higher ODI scores indicate greater disability.
Time frame: Single assessment at baseline
Plan to share: No — Individual participant data are not planned to be shared publicly due to participant confidentiality and data protection considerations.
No publications or documents are linked to this record.
Started Oct 2026 (actual). Primary completion is estimated for Feb 2027, 4 months after the start.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.